Leslie Hammersmith, MA Cancer Research Advocate Senior Manager and eLearning Analyst University of Illinois at Urbana-Champaign Social Media Basics for Clinical Research November 9, 2013 Circle City Chapter of ACRP: 13 th Annual Fall Symposium: Excellence in Clinical Research
40
Embed
ACRP 2013 Fall Symposium: Social Media Basics for Clinical Research
This was presented by Leslie Hammersmith at Circle City Chapter of ACRP 2013 Fall Symposium: Excellence in Clinical Research, Saturday, November 9, 2013.
Understand how social media and mobile technologies are changing the way we can and should be interacting with patients about clinical research. Understand how our use of social media can enhance the value of social media for everyone.
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Leslie Hammersmith, MACancer Research AdvocateSenior Manager and eLearning AnalystUniversity of Illinois at Urbana-Champaign
Social Media Basics for Clinical Research
November 9, 2013Circle City Chapter of ACRP: 13th Annual Fall Symposium: Excellence in Clinical Research
• 6 year breast cancer survivor• Senior Manager and eLearning
Analyst in higher education• Trained cancer research advocate
• AACR• Research Advocacy Network• NCCTG• Young Survival Coalition Research Think Tank• NBCC Project LEAD Institute• DOD Breast Cancer Research Program
OVERALL SYMPOSIUM OBJECTIVES
Name major pieces of legislation impacting research as well as be able to predict how the changes may impact their organizations and be able to organize a plan to adhere to the new laws.
Describe key concepts and competencies needed to self-monitor a clinical trial.
Describe how social media can enhance
site/sponsor relationships and evaluate the impact of technology-enhanced communication on the clinical trial process.
Identify issues that can adversely affect the quality of clinical research trials and describe actions they can take to eliminate and prevent quality issues from happening.
Discuss changes in regulations relating to FDA requirements for medical devices.
Assess The Sunshine Act in order to anticipate and prepare for necessary requirements in their clinical trial processes.